Observation of therapeutic effect of diarrhea-predominant irritable bowel syndrome treated by combination of Berberine and lived combined B. Subtilis and E. Faecium enteric-coated capsules
Yajun Li
Abstract
Yajun Li
Abstract
Objective To observe the therapeutic effect of diarrhea-predominant irritable bowel syndrome treated by combination of Berberine and lived combined B.Subtilis and E.Faecium enteric-coated capsules(Medilac-s).Methods 80 cases of diarrhea-predominant irritable bowel syndrome were randomly divided into two groups.40 patients were in each group.Patients in treatment group were treated by combination of Berberine(300 mg,thrice a day) and Medilac-s(2 pills,thrice a day).40 cases in control group were treated by Berberine(300 mg,thrice a day).The course was three weeks in two groups.Results The total effective rate in treatment group(90%) was higher than that in control group(72.5%,P0.05).Conclusion Combination of Berberine and Medilac-s is safe,effective and inexpensive on the treatment of diarrhea-predominant irritable bowel syndrome.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the therapeutic effect of diarrhea-predominant irritable bowel syndrome treated by combination of Berberine and lived combined B.Subtilis and E.Faecium enteric-coated capsules(Medilac-s).Methods 80 cases of diarrhea-predominant irritable bowel syndrome were randomly divided into two groups.40 patients were in each group.Patients in treatment group were treated by combination of Berberine(300 mg,thrice a day) and Medilac-s(2 pills,thrice a day).40 cases in control group were treated by Berberine(300 mg,thrice a day).The course was three weeks in two groups.Results The total effective rate in treatment group(90%) was higher than that in control group(72.5%,P0.05).Conclusion Combination of Berberine and Medilac-s is safe,effective and inexpensive on the treatment of diarrhea-predominant irritable bowel syndrome.
Key concepts: Irritable bowel syndrome, Medicine, Diarrhea, Berberine, Gastroenterology, Internal medicine, Therapeutic effect, Defecation